Home › Funds › Alpha Advisors, LLC/VA › PGEN
Alpha Advisors, LLC/VA position in PGEN
PRECIGEN INC · Health Care
Alpha Advisors, LLC/VA reported holding 20,230 shares of PGEN (PRECIGEN INC) in its Q3 2026 13F filing — a position valued at US$173K, representing 0.13% of its reported portfolio and ranking #49 among its reported holdings. Alpha Advisors, LLC/VA has disclosed PGEN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR
How Alpha Advisors, LLC/VA's PGEN position evolved
Alpha Advisors, LLC/VA first disclosed a stake in PGEN in Q4 2024 at 20,230 shares (US$23K). The position peaked in Q3 2026 at 20,230 shares, worth US$173K. Across 8 filings, Alpha Advisors, LLC/VA held the position steady without any share-count change. The most recent filing (Q3 2026) shows 20,230 shares valued at US$173K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 20.23K | $22.66K | New |
| Q1 2025 | 20.23K | $30.14K | Hold |
| Q2 2025 | 20.23K | $28.73K | Hold |
| Q3 2025 | 20.23K | $66.56K | Hold |
| Q4 2025 | 20.23K | $84.56K | Hold |
| Q1 2026 | 20.23K | $78.29K | Hold |
| Q2 2026 | 20.23K | $115.31K | Hold |
| Q3 2026 | 20.23K | $173.17K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PGEN and 13F data
PGEN (PRECIGEN INC) is a Health Care company. 59 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$108.5M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), Boxer Capital Management, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PGEN
- Patient Capital Management, LLC 19.04M sh · $108.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 6.42M sh · $36.58M · Q2 2026
- Boxer Capital Management, LLC 5.15M sh · $29.36M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 4.03M sh · $22.98M · Q2 2026
- Diametric Capital, LP 1.41M sh · $8.05M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 683.42K sh · $5.85M · Q3 2026
- LexAurum Advisors, LLC 633.53K sh · $5.42M · Q3 2026
- GMT CAPITAL CORP 668.83K sh · $3.81M · Q2 2026
- Lansing Street Advisors 495.42K sh · $2.82M · Q2 2026
- Occam Crest Management LP 35.50K sh · $2.49M · Q2 2026
More on Alpha Advisors, LLC/VA
FAQ
How long has Alpha Advisors, LLC/VA held PGEN?
Alpha Advisors, LLC/VA has disclosed PGEN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Alpha Advisors, LLC/VA's current position in PGEN?
As of Q3 2026, Alpha Advisors, LLC/VA holds 20.23K shares of PGEN (PRECIGEN INC), valued at $173.17K, representing 0.13% of its reported portfolio and ranking #49.
Has Alpha Advisors, LLC/VA been buying or selling PGEN?
In the latest 13F filing (Q3 2026), Alpha Advisors, LLC/VA held unchanged its position in PGEN. The position peaked in Q3 2026 at 20.23K shares.
Which other funds hold PGEN?
Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.